Global Anthrax Vaccines Market Growth 2022-2028

Global Anthrax Vaccines Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anthrax Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anthrax Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anthrax Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Anthrax Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell free PA Vaccines
2.3 Anthrax Vaccines Sales by Type
2.3.1 Global Anthrax Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anthrax Vaccines Sale Price by Type (2017-2022)
2.4 Anthrax Vaccines Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Anthrax Vaccines Sales by Application
2.5.1 Global Anthrax Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Anthrax Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anthrax Vaccines Sale Price by Application (2017-2022)
3 Global Anthrax Vaccines by Company
3.1 Global Anthrax Vaccines Breakdown Data by Company
3.1.1 Global Anthrax Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Anthrax Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Anthrax Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Anthrax Vaccines Revenue by Company (2020-2022)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Anthrax Vaccines Sale Price by Company
3.4 Key Manufacturers Anthrax Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anthrax Vaccines Product Location Distribution
3.4.2 Players Anthrax Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anthrax Vaccines by Geographic Region
4.1 World Historic Anthrax Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Anthrax Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anthrax Vaccines Annual Revenue by Geographic Region
4.2 World Historic Anthrax Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Anthrax Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anthrax Vaccines Annual Revenue by Country/Region
4.3 Americas Anthrax Vaccines Sales Growth
4.4 APAC Anthrax Vaccines Sales Growth
4.5 Europe Anthrax Vaccines Sales Growth
4.6 Middle East & Africa Anthrax Vaccines Sales Growth
5 Americas
5.1 Americas Anthrax Vaccines Sales by Country
5.1.1 Americas Anthrax Vaccines Sales by Country (2017-2022)
5.1.2 Americas Anthrax Vaccines Revenue by Country (2017-2022)
5.2 Americas Anthrax Vaccines Sales by Type
5.3 Americas Anthrax Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anthrax Vaccines Sales by Region
6.1.1 APAC Anthrax Vaccines Sales by Region (2017-2022)
6.1.2 APAC Anthrax Vaccines Revenue by Region (2017-2022)
6.2 APAC Anthrax Vaccines Sales by Type
6.3 APAC Anthrax Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anthrax Vaccines by Country
7.1.1 Europe Anthrax Vaccines Sales by Country (2017-2022)
7.1.2 Europe Anthrax Vaccines Revenue by Country (2017-2022)
7.2 Europe Anthrax Vaccines Sales by Type
7.3 Europe Anthrax Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anthrax Vaccines by Country
8.1.1 Middle East & Africa Anthrax Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anthrax Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Anthrax Vaccines Sales by Type
8.3 Middle East & Africa Anthrax Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anthrax Vaccines
10.3 Manufacturing Process Analysis of Anthrax Vaccines
10.4 Industry Chain Structure of Anthrax Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anthrax Vaccines Distributors
11.3 Anthrax Vaccines Customer
12 World Forecast Review for Anthrax Vaccines by Geographic Region
12.1 Global Anthrax Vaccines Market Size Forecast by Region
12.1.1 Global Anthrax Vaccines Forecast by Region (2023-2028)
12.1.2 Global Anthrax Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anthrax Vaccines Forecast by Type
12.7 Global Anthrax Vaccines Forecast by Application
13 Key Players Analysis
13.1 Emergent BioSolutions
13.1.1 Emergent BioSolutions Company Information
13.1.2 Emergent BioSolutions Anthrax Vaccines Product Offered
13.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Emergent BioSolutions Main Business Overview
13.1.5 Emergent BioSolutions Latest Developments
13.2 Merial
13.2.1 Merial Company Information
13.2.2 Merial Anthrax Vaccines Product Offered
13.2.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merial Main Business Overview
13.2.5 Merial Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Anthrax Vaccines Product Offered
13.3.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Zoetis
13.4.1 Zoetis Company Information
13.4.2 Zoetis Anthrax Vaccines Product Offered
13.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Zoetis Main Business Overview
13.4.5 Zoetis Latest Developments
13.5 Bayer Sanidad Animal
13.5.1 Bayer Sanidad Animal Company Information
13.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Offered
13.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer Sanidad Animal Main Business Overview
13.5.5 Bayer Sanidad Animal Latest Developments
13.6 Colorado Serum
13.6.1 Colorado Serum Company Information
13.6.2 Colorado Serum Anthrax Vaccines Product Offered
13.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Colorado Serum Main Business Overview
13.6.5 Colorado Serum Latest Developments
13.7 PharmAthene
13.7.1 PharmAthene Company Information
13.7.2 PharmAthene Anthrax Vaccines Product Offered
13.7.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PharmAthene Main Business Overview
13.7.5 PharmAthene Latest Developments
13.8 Tiankang
13.8.1 Tiankang Company Information
13.8.2 Tiankang Anthrax Vaccines Product Offered
13.8.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Tiankang Main Business Overview
13.8.5 Tiankang Latest Developments
13.9 Biogénesis-Bago
13.9.1 Biogénesis-Bago Company Information
13.9.2 Biogénesis-Bago Anthrax Vaccines Product Offered
13.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Biogénesis-Bago Main Business Overview
13.9.5 Biogénesis-Bago Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Anthrax Vaccines Product Offered
13.10.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Rosenbusch
13.11.1 Rosenbusch Company Information
13.11.2 Rosenbusch Anthrax Vaccines Product Offered
13.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Rosenbusch Main Business Overview
13.11.5 Rosenbusch Latest Developments
13.12 Agrovet
13.12.1 Agrovet Company Information
13.12.2 Agrovet Anthrax Vaccines Product Offered
13.12.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Agrovet Main Business Overview
13.12.5 Agrovet Latest Developments
13.13 Vecol
13.13.1 Vecol Company Information
13.13.2 Vecol Anthrax Vaccines Product Offered
13.13.3 Vecol Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Vecol Main Business Overview
13.13.5 Vecol Latest Developments
13.14 CVCRI
13.14.1 CVCRI Company Information
13.14.2 CVCRI Anthrax Vaccines Product Offered
13.14.3 CVCRI Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 CVCRI Main Business Overview
13.14.5 CVCRI Latest Developments
13.15 IVPM
13.15.1 IVPM Company Information
13.15.2 IVPM Anthrax Vaccines Product Offered
13.15.3 IVPM Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 IVPM Main Business Overview
13.15.5 IVPM Latest Developments
13.16 Prondil
13.16.1 Prondil Company Information
13.16.2 Prondil Anthrax Vaccines Product Offered
13.16.3 Prondil Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Prondil Main Business Overview
13.16.5 Prondil Latest Developments
13.17 CDV
13.17.1 CDV Company Information
13.17.2 CDV Anthrax Vaccines Product Offered
13.17.3 CDV Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 CDV Main Business Overview
13.17.5 CDV Latest Developments
13.18 Indian Immunologicals
13.18.1 Indian Immunologicals Company Information
13.18.2 Indian Immunologicals Anthrax Vaccines Product Offered
13.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Indian Immunologicals Main Business Overview
13.18.5 Indian Immunologicals Latest Developments
13.19 Botswana Vaccine Institute
13.19.1 Botswana Vaccine Institute Company Information
13.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Offered
13.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Botswana Vaccine Institute Main Business Overview
13.19.5 Botswana Vaccine Institute Latest Developments
13.20 Ceva Santé Animale
13.20.1 Ceva Santé Animale Company Information
13.20.2 Ceva Santé Animale Anthrax Vaccines Product Offered
13.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Ceva Santé Animale Main Business Overview
13.20.5 Ceva Santé Animale Latest Developments
13.21 Intervac
13.21.1 Intervac Company Information
13.21.2 Intervac Anthrax Vaccines Product Offered
13.21.3 Intervac Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Intervac Main Business Overview
13.21.5 Intervac Latest Developments
13.22 JOVAC
13.22.1 JOVAC Company Information
13.22.2 JOVAC Anthrax Vaccines Product Offered
13.22.3 JOVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 JOVAC Main Business Overview
13.22.5 JOVAC Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anthrax Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anthrax Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Cell free PA Vaccines
Table 5. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 6. Global Anthrax Vaccines Sales Market Share by Type (2017-2022)
Table 7. Global Anthrax Vaccines Revenue by Type (2017-2022) & ($ million)
Table 8. Global Anthrax Vaccines Revenue Market Share by Type (2017-2022)
Table 9. Global Anthrax Vaccines Sale Price by Type (2017-2022) & (USD/Dose)
Table 10. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 11. Global Anthrax Vaccines Sales Market Share by Application (2017-2022)
Table 12. Global Anthrax Vaccines Revenue by Application (2017-2022)
Table 13. Global Anthrax Vaccines Revenue Market Share by Application (2017-2022)
Table 14. Global Anthrax Vaccines Sale Price by Application (2017-2022) & (USD/Dose)
Table 15. Global Anthrax Vaccines Sales by Company (2020-2022) & (M Doses)
Table 16. Global Anthrax Vaccines Sales Market Share by Company (2020-2022)
Table 17. Global Anthrax Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Anthrax Vaccines Revenue Market Share by Company (2020-2022)
Table 19. Global Anthrax Vaccines Sale Price by Company (2020-2022) & (USD/Dose)
Table 20. Key Manufacturers Anthrax Vaccines Producing Area Distribution and Sales Area
Table 21. Players Anthrax Vaccines Products Offered
Table 22. Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anthrax Vaccines Sales by Geographic Region (2017-2022) & (M Doses)
Table 26. Global Anthrax Vaccines Sales Market Share Geographic Region (2017-2022)
Table 27. Global Anthrax Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Anthrax Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Anthrax Vaccines Sales by Country/Region (2017-2022) & (M Doses)
Table 30. Global Anthrax Vaccines Sales Market Share by Country/Region (2017-2022)
Table 31. Global Anthrax Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Anthrax Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 34. Americas Anthrax Vaccines Sales Market Share by Country (2017-2022)
Table 35. Americas Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Anthrax Vaccines Revenue Market Share by Country (2017-2022)
Table 37. Americas Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 38. Americas Anthrax Vaccines Sales Market Share by Type (2017-2022)
Table 39. Americas Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 40. Americas Anthrax Vaccines Sales Market Share by Application (2017-2022)
Table 41. APAC Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
Table 42. APAC Anthrax Vaccines Sales Market Share by Region (2017-2022)
Table 43. APAC Anthrax Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Anthrax Vaccines Revenue Market Share by Region (2017-2022)
Table 45. APAC Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 46. APAC Anthrax Vaccines Sales Market Share by Type (2017-2022)
Table 47. APAC Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 48. APAC Anthrax Vaccines Sales Market Share by Application (2017-2022)
Table 49. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 50. Europe Anthrax Vaccines Sales Market Share by Country (2017-2022)
Table 51. Europe Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Anthrax Vaccines Revenue Market Share by Country (2017-2022)
Table 53. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 54. Europe Anthrax Vaccines Sales Market Share by Type (2017-2022)
Table 55. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 56. Europe Anthrax Vaccines Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
Table 58. Middle East & Africa Anthrax Vaccines Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Anthrax Vaccines Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
Table 62. Middle East & Africa Anthrax Vaccines Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
Table 64. Middle East & Africa Anthrax Vaccines Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Anthrax Vaccines
Table 66. Key Market Challenges & Risks of Anthrax Vaccines
Table 67. Key Industry Trends of Anthrax Vaccines
Table 68. Anthrax Vaccines Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Anthrax Vaccines Distributors List
Table 71. Anthrax Vaccines Customer List
Table 72. Global Anthrax Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 73. Global Anthrax Vaccines Sales Market Forecast by Region
Table 74. Global Anthrax Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Anthrax Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Anthrax Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 77. Americas Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Anthrax Vaccines Sales Forecast by Region (2023-2028) & (M Doses)
Table 79. APAC Anthrax Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Anthrax Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 81. Europe Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Anthrax Vaccines Sales Forecast by Country (2023-2028) & (M Doses)
Table 83. Middle East & Africa Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Anthrax Vaccines Sales Forecast by Type (2023-2028) & (M Doses)
Table 85. Global Anthrax Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Anthrax Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Anthrax Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Anthrax Vaccines Sales Forecast by Application (2023-2028) & (M Doses)
Table 89. Global Anthrax Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Anthrax Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Anthrax Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 92. Emergent BioSolutions Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Emergent BioSolutions Anthrax Vaccines Product Offered
Table 94. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 95. Emergent BioSolutions Main Business
Table 96. Emergent BioSolutions Latest Developments
Table 97. Merial Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Merial Anthrax Vaccines Product Offered
Table 99. Merial Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Merial Main Business
Table 101. Merial Latest Developments
Table 102. Merck Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Anthrax Vaccines Product Offered
Table 104. Merck Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Merck Main Business
Table 106. Merck Latest Developments
Table 107. Zoetis Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Zoetis Anthrax Vaccines Product Offered
Table 109. Zoetis Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 110. Zoetis Main Business
Table 111. Zoetis Latest Developments
Table 112. Bayer Sanidad Animal Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Bayer Sanidad Animal Anthrax Vaccines Product Offered
Table 114. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 115. Bayer Sanidad Animal Main Business
Table 116. Bayer Sanidad Animal Latest Developments
Table 117. Colorado Serum Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Colorado Serum Anthrax Vaccines Product Offered
Table 119. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 120. Colorado Serum Main Business
Table 121. Colorado Serum Latest Developments
Table 122. PharmAthene Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. PharmAthene Anthrax Vaccines Product Offered
Table 124. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 125. PharmAthene Main Business
Table 126. PharmAthene Latest Developments
Table 127. Tiankang Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Tiankang Anthrax Vaccines Product Offered
Table 129. Tiankang Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 130. Tiankang Main Business
Table 131. Tiankang Latest Developments
Table 132. Biogénesis-Bago Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Biogénesis-Bago Anthrax Vaccines Product Offered
Table 134. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 135. Biogénesis-Bago Main Business
Table 136. Biogénesis-Bago Latest Developments
Table 137. CAVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. CAVAC Anthrax Vaccines Product Offered
Table 139. CAVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 140. CAVAC Main Business
Table 141. CAVAC Latest Developments
Table 142. Rosenbusch Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Rosenbusch Anthrax Vaccines Product Offered
Table 144. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 145. Rosenbusch Main Business
Table 146. Rosenbusch Latest Developments
Table 147. Agrovet Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Agrovet Anthrax Vaccines Product Offered
Table 149. Agrovet Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 150. Agrovet Main Business
Table 151. Agrovet Latest Developments
Table 152. Vecol Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Vecol Anthrax Vaccines Product Offered
Table 154. Vecol Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 155. Vecol Main Business
Table 156. Vecol Latest Developments
Table 157. CVCRI Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. CVCRI Anthrax Vaccines Product Offered
Table 159. CVCRI Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 160. CVCRI Main Business
Table 161. CVCRI Latest Developments
Table 162. IVPM Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. IVPM Anthrax Vaccines Product Offered
Table 164. IVPM Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 165. IVPM Main Business
Table 166. IVPM Latest Developments
Table 167. Prondil Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. Prondil Anthrax Vaccines Product Offered
Table 169. Prondil Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 170. Prondil Main Business
Table 171. Prondil Latest Developments
Table 172. CDV Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. CDV Anthrax Vaccines Product Offered
Table 174. CDV Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 175. CDV Main Business
Table 176. CDV Latest Developments
Table 177. Indian Immunologicals Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. Indian Immunologicals Anthrax Vaccines Product Offered
Table 179. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 180. Indian Immunologicals Main Business
Table 181. Indian Immunologicals Latest Developments
Table 182. Botswana Vaccine Institute Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 183. Botswana Vaccine Institute Anthrax Vaccines Product Offered
Table 184. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 185. Botswana Vaccine Institute Main Business
Table 186. Botswana Vaccine Institute Latest Developments
Table 187. Ceva Santé Animale Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 188. Ceva Santé Animale Anthrax Vaccines Product Offered
Table 189. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 190. Ceva Santé Animale Main Business
Table 191. Ceva Santé Animale Latest Developments
Table 192. Intervac Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 193. Intervac Anthrax Vaccines Product Offered
Table 194. Intervac Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 195. Intervac Main Business
Table 196. Intervac Latest Developments
Table 197. JOVAC Basic Information, Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 198. JOVAC Anthrax Vaccines Product Offered
Table 199. JOVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 200. JOVAC Main Business
Table 201. JOVAC Latest Developments
List of Figures
Figure 1. Picture of Anthrax Vaccines
Figure 2. Anthrax Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anthrax Vaccines Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Anthrax Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Anthrax Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Cell free PA Vaccines
Figure 11. Global Anthrax Vaccines Sales Market Share by Type in 2021
Figure 12. Global Anthrax Vaccines Revenue Market Share by Type (2017-2022)
Figure 13. Anthrax Vaccines Consumed in Human Use
Figure 14. Global Anthrax Vaccines Market: Human Use (2017-2022) & (M Doses)
Figure 15. Anthrax Vaccines Consumed in Animal Use
Figure 16. Global Anthrax Vaccines Market: Animal Use (2017-2022) & (M Doses)
Figure 17. Global Anthrax Vaccines Sales Market Share by Application (2017-2022)
Figure 18. Global Anthrax Vaccines Revenue Market Share by Application in 2021
Figure 19. Anthrax Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Anthrax Vaccines Revenue Market Share by Company in 2021
Figure 21. Global Anthrax Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Anthrax Vaccines Revenue Market Share by Geographic Region in 2021
Figure 23. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)
Figure 24. Global Anthrax Vaccines Revenue Market Share by Country/Region in 2021
Figure 25. Americas Anthrax Vaccines Sales 2017-2022 (M Doses)
Figure 26. Americas Anthrax Vaccines Revenue 2017-2022 ($ Millions)
Figure 27. APAC Anthrax Vaccines Sales 2017-2022 (M Doses)
Figure 28. APAC Anthrax Vaccines Revenue 2017-2022 ($ Millions)
Figure 29. Europe Anthrax Vaccines Sales 2017-2022 (M Doses)
Figure 30. Europe Anthrax Vaccines Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Anthrax Vaccines Sales 2017-2022 (M Doses)
Figure 32. Middle East & Africa Anthrax Vaccines Revenue 2017-2022 ($ Millions)
Figure 33. Americas Anthrax Vaccines Sales Market Share by Country in 2021
Figure 34. Americas Anthrax Vaccines Revenue Market Share by Country in 2021
Figure 35. United States Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Anthrax Vaccines Sales Market Share by Region in 2021
Figure 40. APAC Anthrax Vaccines Revenue Market Share by Regions in 2021
Figure 41. China Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Anthrax Vacci

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs